Trial
NCT01769222
Ipilimumab and Local Radiation for Selected Solid Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
—
Condition
Adult Nasal Type Extranodal NK/T-cell Lymphoma
Intervention
Ipilimumab
Why stopped
Planned Future Study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-24